Nanobrid

Our next generation lipid-polymer hybrid nanotechnology platform allows delivery of “difficult to deliver” active ingredients across a variety of therapeutic areas and clinical indications. Nanobrid Platform is flexible and can be adapted to various routes of administration such as topical, injectables, ocular, nasal etc. to design products with superior value propositions. Nanobrid platform offers flexibility of selecting variety of polymers, lipids, and surfactants to optimize formulation characteristics based on target candidate and desired target product profile.